POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380,550 | -26.3% | 57,054 | +0.1% | 0.00% | – |
| Q2 2023 | $516,212 | +127.1% | 56,977 | +82.2% | 0.00% | – |
| Q1 2023 | $227,340 | +4.2% | 31,271 | +4.5% | 0.00% | – |
| Q4 2022 | $218,240 | -1.2% | 29,937 | +5.0% | 0.00% | – |
| Q3 2022 | $221,000 | +59.0% | 28,524 | +40.4% | 0.00% | – |
| Q2 2022 | $139,000 | +157.4% | 20,321 | +197.3% | 0.00% | – |
| Q1 2022 | $54,000 | +42.1% | 6,835 | 0.0% | 0.00% | – |
| Q4 2021 | $38,000 | – | 6,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,560,984 | $27,526,000 | 6.63% |
| Fairmount Funds Management LLC | 2,833,950 | $21,906,000 | 3.85% |
| JOHNSON & JOHNSON | 1,000,000 | $7,730,000 | 2.28% |
| BVF INC/IL | 5,590,048 | $43,211,000 | 1.78% |
| Affinity Asset Advisors, LLC | 746,576 | $5,771,000 | 1.61% |
| Sio Capital Management, LLC | 544,545 | $4,209,000 | 1.34% |
| PFM Health Sciences, LP | 4,515,216 | $34,903,000 | 1.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,052,842 | $8,138,000 | 1.13% |
| Boxer Capital, LLC | 2,500,000 | $19,325,000 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $2,319,000 | 0.78% |